Gene therapies for kidney diseases via AAV platform targeting podocytes.
Founders
Moin Saleem(United Kingdom · ♂)— A world-leading kidney specialist and academic nephrologist at the University of Bristol, Saleem founded Purespring (launched with Syncona in 2020) to translate his research on the podocyte kidney cell into AAV gene therapies delivered directly to the kidney.
Team & hubs
In the network
Shares the most investors with (number = shared investors):